Health Care/Hospital
Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325
SUZHOU, China, and ROCKVILLE, Md., July 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its global licensee, UNITY Biotechnology, In...
2021-07-29 07:40
4972
Margaret Crotty to lead JSI and World Education family of global agencies
BOSTON, July 29, 2021 /PRNewswire/ -- The JSI Board of Directors has announced the appointment ofMargaret Crotty as its next president and CEO. She will succeedJoel Lamstein, who has served as president and CEO since he founded John Snow, Inc., with Bert Hirschhorn in 1978. Margaret, who has a r...
2021-07-29 02:43
1889
Are Textbooks Holding Back Cures for Cancer?
Famed Researchers Highlight Glaring Omissions About the Power of Our Cells Say Modernizing What We Teach About Our Ability To Influence Evolution Can Change How Medicine Is Practiced OXFORD, England, July 29, 2021 /PRNewswire/ -- Misunderstandings and omissions fromCharles Darwin's theory of evo...
2021-07-29 02:40
2231
Fortacin™ Receives Extremely Encouraging Assessment in US Market Research Analysis
HONG KONG, July 28, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce that Fortacin™, a European,Hong Kong andMacau approved treatment for PE receives a detailed market ass...
2021-07-28 20:05
9117
BIOTRONIK Applauded by Frost & Sullivan for Its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm
LONDON, July 28, 2021 /PRNewswire/ -- Based on its recent analysis of the Global market for implantable cardiac monitoring devices,Frost & Sullivan recognizesBIOTRONIK with the 2021 Global Enabling Technology Leadership Award. The company's subcutaneous miniature, injectable electrocardiogram (EC...
2021-07-28 18:00
1860
Infinitus Co-Organizes the 11th National Conference on Immunology of Traditional Chinese Medicine
GUANGZHOU, China, July 28, 2021 /PRNewswire/ -- The 11th National Conference on Immunology of Traditional Chinese Medicine(TCM) organized by the Immunology of Traditional Chinese Medicine Branch of the Chinese Society for Immunology (CSI) in partnership withShandong University of Traditional Chin...
2021-07-28 17:30
2223
Eccogene Announces Completed First-in-human of ECC0509 in Phase 1a Clinical Trial in Australia
SHANGHAI, July 28, 2021 /PRNewswire/ -- Eccogene, Inc., a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced the initiation of a Phase 1a clinical trial evaluating ECC0509, an oral inhibitor of semicarbazide-sensitive...
2021-07-28 17:13
2919
Ping An Launches Pilot of Digital RMB Insurance Policies with Bank of China in Shenzhen
HONG KONG and SHANGHAI, July 28, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) announced that Ping An Property & Casualty Insurance Company ofChina, Ltd. has issued the first batch of digital RMB insurance polici...
2021-07-28 16:40
13455
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%
HONG KONG, July 28, 2021 /PRNewswire/ -- The faecal immunochemical test (FIT) is commonly used to screen for colorectal cancer but it has low sensitivity (around 50%) for early cancer detection and fails to detect polyps. The Faculty of Medicine at TheChinese University of Hong Kong (CU Medicine)...
2021-07-28 15:09
4920
Q2 2021 Results
Significant revenue improvement and strong margin performance ZURICH, July 28, 2021 /PRNewswire/ -- * Revenues up 29% on an organic,1 trading days adjusted basis ("TDA"), led by Adecco, up 33% organic TDA * Revenue growth strongest in higher-value activities; Permanent Placement up 88% organ...
2021-07-28 12:45
2061
Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System
HANGZHOU, China, July 28, 2021 /PRNewswire/ -- On July 27, 2021, Venus Medtech ( Hangzhou) Inc. ("Venus Medtech") (stock code: 2500.HK), a leading provider of comprehensive interventional heart valve therapy solutions inChina, and its controlling subsidiary Renaly Ltd., announced that Professor...
2021-07-28 11:41
6080
India-based MedTel receives investment term sheet from Catalist-listed Metal Component Engineering (MCE, SGX:5DX)
SINGAPORE, July 28, 2021 /PRNewswire/ -- Catalist-listed Metal Component Engineering Limited ("MCE") is pleased to announce that it has, through its subsidiary, Metal Precision Services Pte Ltd, entered into a term sheet to take an equity stake in MedTel Healthcare Private Limited ("MedTel"). MCE...
2021-07-28 11:36
12121
More than Half of Singaporeans Unaware of Link between Viral Hepatitis and Liver Failure: Survey
* New survey demonstrates general apathy among Singaporeans towards liver health, particularly among those aged 25 and below, despite high rates of liver cancer and failure in the country * Hepatitis B causes 60-70% of total number of liver cancer cases in the country[1]; liver cancer known ...
2021-07-28 11:00
2036
Gilead Sciences Announces Launch of Asia Pacific ALL4LIVER Grant 2021
– Biennial Grant Program Supports Community Projects Focused on Improving Education About Liver Health inSingapore and 10 Other Countries and Territories– – Inaugural Cycle of the Grant will Focus on Hepatitis B Awareness Initiatives – SINGAPORE, July 28, 2021 /PRNewswire/ -- Gilead Sciences, I...
2021-07-28 11:00
4155
Ascletis Announces Completion of 149 Patient Enrollment and Positive Interim Results of Phase IIb Chronic Hepatitis B Study in China for its Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab)
* HBsAg reduction was observed in the 1 mg/kg ASC22 once every two weeks plus nucleos(t)ide analogs group with greater HBsAg reduction observed in patients with HBsAg ≤ 500 IU/mL at baseline while no HBsAg reduction was observed for the placebo plus nucleos(t)ide analogs group * Receptor oc...
2021-07-28 08:30
3705
GeoMe DriveThru Technology to Help Keep Take-Away Businesses Open During Lockdowns
GOLD COAST, Australia, July 28, 2021 /PRNewswire/ -- Gold Coast based tech startup has launchedGeoMe DriveThru, a cloud-based Virtual Drive-Thru (also known as Curbside Pickup) technology that allows businesses to provide contactless, COVID-safe, and efficient pickup of takeaway orders. Using t...
2021-07-28 08:17
1864
Global Dementia Cases Forecasted To Triple By 2050
—New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors DENVER, July 27, 2021 /PRNewswire/ -- Positive trends in global education access are expected to decrease dementia prevalence worldwide by 6.2 million cases by the year 2050. Mean...
2021-07-27 22:00
4412
Deep Longevity Repurposes a Blood Aging Clock for Saliva Samples
HONG KONG, July 27, 2021 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to ann...
2021-07-27 21:39
14684
Presagen Lauded by Frost & Sullivan for Innovating a New Model of Healthcare, Enabling Access to Diverse Global Datasets through Its AI Platform
The platform leverages a large clinical network to obtain data for developing high-performing, globally accessible products SANTA CLARA, Calif., July 27, 2021 /PRNewswire/ -- Based on its recent analysis of the global AI-enhanced healthcare market,Frost & Sullivan recognizes Presagen with the 202...
2021-07-27 21:00
1972
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
SHANGHAI, July 27, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 1...
2021-07-27 20:30
4227
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 316 media titles]
2026-06-08 10:16
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55
Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08
DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 283 media titles]
2026-06-08 09:00
Most Read
YY Group (NASDAQ: YYGH) Wins Prestigious HAPA Solutions Excellence Award, Validating Enterprise AI Marketplace Adoption in Southeast Asia
2026-06-05 19:37
8727
Dreame ranked No.1 in Global Robot Vacuum Sales & Revenue, according to International Data Corporation (IDC)
2026-06-05 21:05
8123
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
2026-06-05 22:00
7633
Tuniu Announces Unaudited First Quarter 2026 Financial Results
2026-06-05 18:00
7564
